Generic Name and Formulations:
Lorazepam 0.5mg, 1mg+, 2mg+; tabs; +scored.
Biovail Pharmaceuticals, Inc.
Indications for ATIVAN:
Give in 2 or 3 divided doses, with largest dose taken at bedtime. Initially 2–3mg daily; range: 1–10mg daily. Elderly or debilitated: initially 1–2mg daily; adjust gradually if needed.
Acute narrow-angle glaucoma.
Therapy for >4 months. Avoid abrupt cessation. Change dose gradually. Discontinue if paradoxical reactions occurs. Drug or alcohol abuse. Depression. Suicidal tendencies. Renal, hepatic, or pulmonary dysfunction. Seizure disorder. Reevaluate periodically. Monitor blood counts, liver function with long-term use. Elderly. Debilitated. Psychosis, pregnancy, nursing mothers: not recommended.
Potentiation of CNS depression with alcohol, other CNS depressants. May be potentiated by probenecid or valproate (reduce lorazepam dose by 50%).
CNS depression (esp. sedation), dizziness, weakness, unsteadiness, transient memory impairment, disorientation, nausea, headache, sleep disturbances, agitation, abuse potential.
0.5mg, 2mg—100; 1mg—100, 1000
- 0.5mg tablets (Qty:30)
- appx. price $463.00
- McDonald's and the Microbiome: What Effect Does Junk Food Have on Gut Bacteria?
- When the Doctor is Depressed: One Clinician Tells His Story
- Most Distinctive Causes of Death Mapped by U.S. State
- Spice + Statin Likely Culprit in Patient with Acute Hepatitis
- First Non-Surgical Tx for "Double Chin" Gains FDA Approval
- Antiviral May Tighten Blood-Brain Barrier Against Pathogens
- Better Outcomes for HIV Patients Who Start Treatment Early, Says Study
- DOD: Live Anthrax Accidentally Sent to Nine States, South Korea
- New OTC Lightweight Wearable Launched for Chronic Pain Relief
- FDA: Beware of Embolization With Dermal Fillers